Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 1
2007 1
2016 1
2018 2
2019 1
2020 3
2021 5
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Soft-tissue sarcoma in adolescents and young adults.
Kunisada T, Nakata E, Fujiwara T, Hosono A, Takihira S, Kondo H, Ozaki T. Kunisada T, et al. Among authors: kondo h. Int J Clin Oncol. 2023 Jan;28(1):1-11. doi: 10.1007/s10147-022-02119-7. Epub 2022 Jan 27. Int J Clin Oncol. 2023. PMID: 35084598 Review.
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
Fujiwara T, Yakoub MA, Chandler A, Christ AB, Yang G, Ouerfelli O, Rajasekhar VK, Yoshida A, Kondo H, Hata T, Tazawa H, Dogan Y, Moore MAS, Fujiwara T, Ozaki T, Purdue E, Healey JH. Fujiwara T, et al. Among authors: kondo h. Mol Cancer Ther. 2021 Aug;20(8):1388-1399. doi: 10.1158/1535-7163.MCT-20-0591. Epub 2021 Jun 4. Mol Cancer Ther. 2021. PMID: 34088832 Free PMC article.
Role of Tumor-Associated Macrophages in Sarcomas.
Fujiwara T, Healey J, Ogura K, Yoshida A, Kondo H, Hata T, Kure M, Tazawa H, Nakata E, Kunisada T, Fujiwara T, Ozaki T. Fujiwara T, et al. Among authors: kondo h. Cancers (Basel). 2021 Mar 3;13(5):1086. doi: 10.3390/cancers13051086. Cancers (Basel). 2021. PMID: 33802565 Free PMC article. Review.
Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression.
Sugiu K, Tazawa H, Hasei J, Yamakawa Y, Omori T, Komatsubara T, Mochizuki Y, Kondo H, Osaki S, Fujiwara T, Yoshida A, Kunisada T, Ueda K, Urata Y, Kagawa S, Ozaki T, Fujiwara T. Sugiu K, et al. Among authors: kondo h. Cancer Chemother Pharmacol. 2021 Sep;88(3):513-524. doi: 10.1007/s00280-021-04310-5. Epub 2021 Jun 10. Cancer Chemother Pharmacol. 2021. PMID: 34114067 Free article.
Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcoma.
Mochizuki Y, Tazawa H, Demiya K, Kure M, Kondo H, Komatsubara T, Sugiu K, Hasei J, Yoshida A, Kunisada T, Urata Y, Kagawa S, Ozaki T, Fujiwara T. Mochizuki Y, et al. Among authors: kondo h. Cancer Immunol Immunother. 2021 May;70(5):1405-1417. doi: 10.1007/s00262-020-02774-7. Epub 2020 Nov 5. Cancer Immunol Immunother. 2021. PMID: 33151368 Free PMC article.
Clinical Outcome of Patients with Pelvic and Retroperitoneal Bone and Soft Tissue Sarcoma: A Retrospective Multicenter Study in Japan.
Takemori T, Kawamoto T, Hara H, Fukase N, Fujiwara S, Fujita I, Fujimoto T, Morishita M, Kitayama K, Yahiro S, Miyamoto T, Saito M, Sugaya J, Hayashi K, Kawashima H, Torigoe T, Nakamura T, Kondo H, Wakamatsu T, Watanuki M, Kito M, Tsukushi S, Nagano A, Outani H, Toki S, Nishimura S, Kobayashi H, Watanabe I, Demizu Y, Sasaki R, Fukumoto T, Niikura T, Kuroda R, Akisue T. Takemori T, et al. Among authors: kondo h. Cancers (Basel). 2022 Jun 20;14(12):3023. doi: 10.3390/cancers14123023. Cancers (Basel). 2022. PMID: 35740688 Free PMC article.
18 results